BLTE Stock Analysis: Buy, Sell, or Hold?
BLTE - Belite Bio, Inc American Depositary Shares
$146.63
4.32 (3.04%)
▲
5d:
-2.14%
30d:
+8.67%
90d:
-12.33%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When BLTE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: BLTE trading at deep discount. Market pricing in -5.4% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: BLTE trading at deep discount. Market pricing in -5.4% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$33.08
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$20.54
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BLTE is currently trading at $146.63, which is considered fair relative to its 30-day fair value range of $138.98 to $149.30. From a valuation perspective, the stock is trading at a discount (Forward PE: 155.3) compared to its historical average (183.4). Remarkably, the market is currently pricing in an annual earnings decline of 5.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BLTE is in a strong downtrend. Immediate support is located at $140.99, while resistance sits at $157.99. The stock is showing strong short-term momentum, up 3.0% recently.
Market Sentiment: BLTE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $210.50 (+43.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BLTE is in a strong downtrend. Immediate support is located at $140.99, while resistance sits at $157.99. The stock is showing strong short-term momentum, up 3.0% recently.
Market Sentiment: BLTE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $210.50 (+43.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$138.98 -
$149.30
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
88.1%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.0%)
- BULLISH: Trading 43.6% below Wall St target ($210.50)
Trading Range Analysis
30-Day Trading Range
$138.98 -
$149.30
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$140.99
Resistance Level
$157.99
Current Trend
Strong Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
155.28
Wall Street Target
$210.50
(+43.6%)
Valuation Discount vs History
-5.4% cheaper
PE vs Historical
155.3 vs 183.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.4%
(market-implied from PE analysis)
1-Year Target
$138.71
(-5%)
2-Year Target
$131.22
(-11%)
3-Year Target
$124.14
(-15%)
3-Yr Target (if PE normalizes)
(PE: 155→183)
$146.62
(0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 155.3 to 183.4
Stabilization Target:
$173.18
(+18.1%)
PE Expansion Potential:
+18.1%
Share & Embed Analysis
Last updated: July 03, 2026 5:41 PM ET
Data refreshes hourly during market hours. Next update: 6:41 PM
Data refreshes hourly during market hours. Next update: 6:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLTE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Nathan L Mata
SELL
1000 shares
2026-04-22
Nathan L Mata
SELL
1000 shares
2026-04-20
Nathan L Mata
SELL
1000 shares
2026-04-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 55 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 59 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 63 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 63 BUY |
